TD Asset Management
SUPN icon

TD Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

TD Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,800
Closed -$404K – 1388
2015
Q3 		$404K Buy
28,800
+1,000
+4% +$18.6K ﹤0.01% 1124
2015
Q2 		$472K Buy
27,800
+2,900
+12% +$41.3K ﹤0.01% 1130
2015
Q1 		$301K Sell
24,900
-7,400
-23% -$69.9K ﹤0.01% 1240
2014
Q4 		$268K Sell
32,300
-21,300
-40% -$179K ﹤0.01% 1261
2014
Q3 		$466K Sell
53,600
-26,100
-33% -$236K ﹤0.01% 1057
2014
Q2 		$873K Sell
79,700
-35,400
-31% -$315K ﹤0.01% 917
2014
Q1 		$1.03M Buy
115,100
+9,500
+9% +$87.5K ﹤0.01% 904
2013
Q4 		$796K Buy
105,600
+1,600
+2% +$11.2K ﹤0.01% 916
2013
Q3 		$762K Buy
104,000
+5,600
+6% +$37.6K ﹤0.01% 910
2013
Q2 		$633K Buy
+98,400
New +$580K ﹤0.01% 895

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TD Asset Management's SUPN Position: Q4 2015 in Review

TD Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2015, closing a stake of 28,800 shares — an estimated $404K sold.

TD Asset Management first reported a position in SUPN in Q2 2013 and held it in 10 quarters. The position peaked at $1.03M in Q1 2014. 209 funds tracked by Wall St. Rank hold SUPN as of Q4 2015.

  • TD Asset Management reported no remaining Supernus Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • TD Asset Management sold 28,800 Supernus Pharmaceuticals shares in Q4 2015, an estimated $404K.
  • TD Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • TD Asset Management's Supernus Pharmaceuticals position peaked at $1.03M in Q1 2014.
  • 209 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2015.

Based on TD Asset Management's 13F filing for Q4 2015, filed 4 Feb 2016.